文献速递妇科肿瘤乳腺癌

BRCA1和BRCA2序列变异女性的双侧卵巢切除术与全因死亡率

Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations.
PubMed 文献 · JAMA Oncol · 2024-01-01

这项国际纵向队列研究纳入4332例无癌症史的BRCA1或BRCA2序列变异女性,随访期间2932例(67.8%)接受了预防性卵巢切除术。校正年龄后,卵巢切除术与全因死亡率显著降低相关(HR 0.32,95%CI 0.24-0.42,P<.001);BRCA1和BRCA2序列变异女性的HR分别为0.28和0.43。

要点

  • BRCA1/2序列变异女性中,卵巢切除术与全因死亡率显著降低相关(HR 0.32,95%CI 0.24-0.42)。
  • BRCA1序列变异女性卵巢切除术的年龄校正HR为0.28(95%CI 0.20-0.38,P<.001)。
  • BRCA2序列变异女性卵巢切除术的年龄校正HR为0.43(95%CI 0.22-0.90,P=.03)。

核心结论

  • 在BRCA1或BRCA2序列变异女性中,卵巢切除术与全因死亡率显著降低相关。

研究设计与样本

  • 国际纵向队列研究,纳入4332例无癌症史的BRCA1或BRCA2序列变异女性,平均年龄42.6岁,随访至75岁。
  • 双侧卵巢切除术信息通过每两年一次问卷获取,采用Cox比例风险回归(时间依赖)估计全因死亡HR和95%CI。
  • 数据分析时间为2023年1月1日至6月1日。

主要发现

  • 2932例(67.8%)女性接受预防性卵巢切除术,平均(范围)年龄45.4(23.0-77.0)岁。
  • 平均随访9.0年,851例发生癌症,228例死亡;其中57例死于卵巢或输卵管癌,58例死于乳腺癌,16例死于腹膜癌,97例死于其他原因。
  • 卵巢切除术与全因死亡率相关的年龄校正HR为0.32(95%CI 0.24-0.42,P<.001)。
  • BRCA1序列变异女性年龄校正HR为0.28(95%CI 0.20-0.38,P<.001),BRCA2序列变异女性为0.43(95%CI 0.22-0.90,P=.03)。
  • BRCA1序列变异女性35岁行卵巢切除术者至75岁累积全因死亡率估计为25%,未行卵巢切除术者为62%;BRCA2序列变异女性分别为14%和28%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Preventive bilateral salpingo-oophorectomy is offered to women at high risk of ovarian cancer who carry a pathogenic variant in BRCA1 or BRCA2; however, the association of oophorectomy with all-cause mortality has not been clearly defined. OBJECTIVE: To evaluate the association between bilateral oophorectomy and all-cause mortality among women with a BRCA1 or BRCA2 sequence variation. DESIGN, SETTING, AND PARTICIPANTS: In this international, longitudinal cohort study of women with BRCA sequence variations, information on bilateral oophorectomy was obtained via biennial questionnaire. Participants were women with a BRCA1 or BRCA2 sequence variation, no prior history of cancer, and at least 1 follow-up questionnaire completed. Women were followed up from age 35 to 75 years for incident cancers and deaths. Cox proportional hazards regression was used to estimate the hazard ratios (HRs) and 95% CIs for all-cause mortality associated with a bilateral oophorectomy (time dependent). Data analysis was performed from January 1 to June 1, 2023. EXPOSURES: Self-reported bilateral oophorectomy (with or without salpingectomy). MAIN OUTCOMES AND MEASURES: All-cause mortality, breast cancer-specific mortality, and ovarian cancer-specific mortality. RESULTS: There were 4332 women (mean age, 42.6 years) enrolled in the cohort, of whom 2932 (67.8%) chose to undergo a preventive oophorectomy at a mean (range) age of 45.4 (23.0-77.0) years. After a mean follow-up of 9.0 years, 851 women had developed cancer and 228 had died; 57 died of ovarian or fallopian tube cancer, 58 died of breast cancer, 16 died of peritoneal cancer, and 97 died of other causes. The age-adjusted HR for all-cause mortality associated with oophorectomy was 0.32 (95% CI, 0.24-0.42; P < .001). The age-adjusted HR was 0.28 (95% CI, 0.20-0.38; P < .001) and 0.43 (95% CI, 0.22-0.90; P = .03) for women with BRCA1 and BRCA2 sequence variations, respectively. For women with BRCA1 sequence variations, the estimated cumulative all-cause mortality to age 75 years for women who had an oophorectomy at age 35 years was 25%, compared to 62% for women who did not have an oophorectomy. For women with BRCA2 sequence variations, the estimated cumulative all-cause mortality to age 75 years was 14% for women who had an oophorectomy at age 35 years compared to 28% for women who did not have an oophorectomy. CONCLUSIONS AND RELEVANCE: In this cohort study among women with a BRCA1 or BRCA2 sequence variation, oophorectomy was associated with a significant reduction in all-cause mortality.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Kotsopoulos J, Gronwald J, Huzarski T, et al. Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations. JAMA Oncol. 2024. PMID: 38421677. doi:10.1001/jamaoncol.2023.6937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。